Sie befinden sind hier: Startseite > Börse > Unternehmensnachrichten > Diamyd Medical AB Sweden

In-depth, Diamyd&reg;

Diamyd Medical AB Sweden

07.08.2025 - 18:06:30

In-depth analysis showing robust Diamyd® treatment effects across clinical trials to be shared at the 2024 IDS Diabetes Congress

View original content:https://www.prnewswire.co.uk/news-releases/in-depth-analysis-showing-robust-diamyd-treatment-effects-across-clinical-trials-to-be-shared-at-the-2024-ids-diabetes-congress-302297338.html

@ prnewswire.co.uk